Breakthrough Therapy Designations Set Quarterly Record

 
• By Michael Cipriano

US FDA granted designations for several products based on late-stage data; with at least 19 breakthrough therapy designations, five-year-old program sets another record in first quarter of 2018.

FDA entrance sign 2016

Breakthrough therapy designations continue to set records at the US FDA – this time another quarterly one.

Publicly announced receipts of the expedited pathway totaled 19 in the first quarter of 2018, according to data from Biomedtracker...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Review Pathways

More from Pathways & Standards